Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain EXAS message board posts where the ticker symbol EXAS has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest EXAS SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-029603 Size: 5 KB
2018-05-11
DEF 14A  Documents Other definitive proxy statements
Acc-no: 0001047469-18-003348 (34 Act)  Size: 3 MB
2018-04-30 001-35092
18789804
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001558370-18-003345 (34 Act)  Size: 9 MB
2018-04-26 001-35092
18779416
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001104659-18-027176 (34 Act)  Size: 127 KB
2018-04-26 001-35092
18778781
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-024873 Size: 4 KB
2018-04-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-024732 Size: 4 KB
2018-04-12
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-024727 Size: 7 KB
2018-04-12
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-023111 Size: 5 KB
2018-04-03
3  Documents Initial statement of beneficial ownership of securities
Acc-no: 0001209191-18-023097 Size: 7 KB
2018-04-03
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-18-023080 Size: 9 KB
2018-04-03
More EXAS SEC Filings


Related news from
Mon, 14 May 2018
10:00:00 +0000
4 Biotech Stocks Set to Rise By 14% or More
Biotech stocks are breaking out, with the SPDR S&P Biotech ETF ( XBI) gearing up for what could be a significant rise higher. Since that time the group has turned higher, and now technical analysis suggests more gains may lie ahead for the sector.
Tue, 08 May 2018
11:20:00 +0000
Recent Analysis Shows Boardwalk Pipeline Partners, Chegg, CommScope Holding, Exact Sciences, HollyFrontier, and Hecla Mining Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, May 08, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Boardwalk ...
Thu, 03 May 2018
16:36:55 +0000
Exact Sciences teams with Vince Lombardi foundation in fight against colon cancer
The new partnership includes the organizations collaborating on national campaigns and donations made to the foundation from the medical device company.
Thu, 03 May 2018
13:00:00 +0000
Vince Lombardi Cancer Foundation and Exact Sciences Team Up to Fight Colon Cancer
MILWAUKEE and MADISON, Wis., May 3, 2018 /PRNewswire/ -- Colon cancer cut short the life of legendary football coach Vince Lombardi at the age of 57 and, nearly 50 years later, remains the number two cancer killer in the United States. Now, the foundation bearing his name and one of the country's premier cancer diagnostics companies are teaming up to fight back. Today, the Vince Lombardi Cancer Foundation (VLCF) announced a new, multi-year partnership with Madison, Wis.-based Exact Sciences that will work to increase awareness of colon cancer, stress the importance of screening and prevention, and raise funds for cancer research.
Wed, 02 May 2018
20:08:00 +0000
[$$] Exact Sciences: A Big Opportunity?
Exact Sciences CEO Kevin Conroy continues to see big growth from the company’s colon-cancer test. Conroy says Exact’s screen, Cologuard, could ultimately deliver revenue of $5 to $6 billion annually, more than 10 times projected 2018 sales, as physicians and U.S. consumers embrace it. “We have an attractive long-term opportunity given the size of the market and our position in it,” Conroy told Barron’s today.
Tue, 01 May 2018
10:00:00 +0000
Exact Sciences to participate in two investor conferences during May
MADISON, Wis., May 1, 2018 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that company management will be presenting at the following investor conferences during May and invited investors to participate by webcast. The webcasts can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com. Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer.
Mon, 30 Apr 2018
12:43:12 +0000
Exact Sciences (EXAS) in Focus: Stock Moves 11.6% Higher
Exact Sciences Corporation (EXAS) was a big mover last session, as the company saw its shares rise nearly 12% on the day.
Fri, 27 Apr 2018
20:29:00 +0000
Why SVB Financial Group, Exact Sciences, and Sprint Jumped Today
Find out how earnings reports helped two of these companies.
Fri, 27 Apr 2018
16:30:00 +0000
Why Exact Sciences Is Soaring Today
Traders cheer after the company reports expectation-smashing results.
Fri, 27 Apr 2018
11:35:08 +0000
Edited Transcript of EXAS earnings conference call or presentation 26-Apr-18 9:00pm GMT
Q1 2018 Exact Sciences Corp Earnings Call
Fri, 27 Apr 2018
09:06:16 +0000
Exact Sciences: 1Q Earnings Snapshot
On a per-share basis, the Madison, Wisconsin-based company said it had a loss of 33 cents. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...
Thu, 26 Apr 2018
21:11:38 +0000
Exact Sciences revenue jumps 87% in first quarter, topping consensus
The company completed 186,000 Cologuard tests during the quarter, also an 87 percent increase from the same quarter in 2017.
Thu, 26 Apr 2018
20:05:00 +0000
Cologuard® revenue and completed tests increased 87 percent to $90.3 million and 186,000
- Nearly 9,000 healthcare providers ordered their initial Cologuard test during the first quarter, and more than 110,000 have ordered since the test was launched MADISON, Wis. , April 26, 2018 /PRNewswire/ ...
Wed, 25 Apr 2018
10:02:00 +0000
Don't Get Greedy With Exact Sciences Corporation Stock
There's a lot to like about Exact Sciences. But don't overlook the risks.
Mon, 16 Apr 2018
12:02:09 +0000
See what the IHS Markit Score report has to say about Exact Sciences Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Fri, 13 Apr 2018
12:20:00 +0000
Today’s Research Reports on Trending Tickers: Exact Sciences and Immunomedics
NEW YORK, NY / ACCESSWIRE / April 13, 2018 / U.S. markets jumped Thursday as investor's attention shifted from current geopolitical tensions to the upcoming earnings season. Bank stocks were the top gainers ...
Tue, 10 Apr 2018
12:20:00 +0000
Today’s Research Reports on Trending Tickers: Exact Sciences and Exelixis
NEW YORK, NY / ACCESSWIRE / April 10, 2018 / U.S. markets rallied in early trading Monday on the strength of technology stocks and the easing of trade relations between the U.S. and China. However, most ...
Mon, 09 Apr 2018
10:00:00 +0000
Exact Sciences schedules first-quarter 2018 earnings call
MADISON, Wis., April 9, 2018 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company plans to release its first-quarter 2018 financial results after the close of the U.S. financial markets on April 26, 2018. Following the release, company management will host a webcast and conference call at 5 p.m. EDT to discuss financial results and business progress.
Mon, 09 Apr 2018
09:31:22 +0000
Exact Sciences Corporation Could Break Out Despite Steep Drop in Biotech
EXAS stock is down almost 29% in the same period. Exact is a promising laboratory and research firm in the business of screening patients for colon cancer. Patient compliance for the screening test is at a modest 65% .
Sun, 08 Apr 2018
13:31:00 +0000
Is Exact Sciences Corp. Still a Buy in 2018?
Shareholders in the innovative colon cancer test specialist have enjoyed huge gains over the last few years.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "This site is a gem, and based on the posts by many members and my personal experience it is a site for learning, sharing and especially making money." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards